Dasatinib for Patients Achieving Complete Molecular Response for Cure D-NewS Trial

Clinical trial NCT01887561 · UNKNOWN

Trial details

NCT number: NCT01887561
Sponsor: Kanto CML Study Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Myelogenous Leukemia, Chronic, Chronic Phase

Start date: 2012-11-01
Primary completion: 2012-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.